All Type of News
Health ministry reaffirms general public cannot run medical institution
The government said it will not allow any individual or corporation to run his/her own clinic or pharmacy by retaining eligible doctors or pharmacists, according to the Ministry of Health, Welfare and Family Affairs.
...
Health insurance to cover new chemically modified drug price up to 90% of original drug
When a chemically modified drug with a new dosage and administration gets listed for insurance coverage, the price will be calculated by 90 percent of the corresponding original drug, the Ministry of Health, Welfare a...
New generic pricing system energizes drug makers
The government’s decision to acknowledge the price of a chemically modified medicine with new dosage and administration up to 90 percent of the corresponding original drug has helped boost the domestic pharmaceutical ...
Hospital overcharges W5.8 billion won
Patients will receive about 5.8 billion won in medical fee refunds because some hospitals overcharged for health insurance coverage, health authorities said on September 8.
The Health Insurance Review & Assessment...
Doctors urged to prescribe VytorinMore caution should be necessary in prescribing Vytorin (ezetimibe/ simvastin) as concern about Vytorin and cancer surfaced in July, when the SEAS study was published, according...
|
Health ministry rules out establishment of medical institution by general public
The government said it will not allow individuals or corporations to own medical institutions, rejecting the news of Korea Broadcasting System (KBS) that the general public or corporations may run hospital or pharmacy...
Government to map out policies for nurturing cGMP professionals
The government should also produce policies that could heighten the competitive power of relatively vulnerable pharmaceutical industry, such as a plan to nurture professional people for proper operation of cCMP plants...
34 pharmaceutical firms adopt compliance program
A total of 34 Korean drug makers have declared launch of a compliance program (CP) for fair trade, according to the Korea Pharmaceutical Manufacturers Association.
“We are going to encourage manufacturers to volunt...
Public hearing on dyslipidemia guideline
The Korean Society of Lipidology and Arteriosclerosis said it has hosted a public hearing to discuss more updated version of clinical practice guideline for the management of dyslipidemia in Korean patients.
Dyslip...
Sudo change name to Wooridul Life Sciences Ltd.Sudo Pharm said it will change its name to Wooridul Life Sciences Ltd. from September 5, citing image renovation as the main reason.
Founded in 1966, the company has set an a...
|
